Human neuronal cells: possibilities in drug safety testing
Drug Target Review
SEPTEMBER 26, 2023
CNS-related issues account for nearly a quarter of failures during clinical development, a phase where consequences are high in terms of resources and patient impact. CNS-related issues account for nearly a quarter of failures during clinical development, a phase where consequences are high in terms of resources and patient impact.
Let's personalize your content